AITech Interview with Hanjo Kim, SVP of Global Strategy, Head of Medicinal Chemistry at Standigm Much of the historical progress has been led by AI-native drug discovery companies that offer software or service to pharma players. https://ai-techpark.com/aitech-interview-with-hanjo-kim/